enGene Holdings Inc. (NASDAQ: ENGN)
$6.2400
-0.0800 ( +2.30% ) 30.0K
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
Market Data
Open
$6.2400
Previous close
$6.3200
Volume
30.0K
Market cap
$322.17M
Day range
$6.0550 - $6.8490
52 week range
$4.4200 - $18.4000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Feb 21, 2024 |
4 | Insider transactions | 1 | Feb 21, 2024 |
8-k | 8K-related | 63 | Feb 14, 2024 |
3 | Insider transactions | 2 | Feb 02, 2024 |
8-k | 8K-related | 14 | Jan 29, 2024 |
10-k | Annual reports | 123 | Jan 29, 2024 |
8-k | 8K-related | 15 | Dec 28, 2023 |
8-k | 8K-related | 14 | Dec 21, 2023 |
3 | Insider transactions | 2 | Dec 19, 2023 |
8-k | 8K-related | 14 | Dec 13, 2023 |